Tuas, Singapore

Tuas, Singapore

API Process Development and Manufacturing for Oligonucleotides, Peptides & Conjugates

Coming soon. The new 50-acre site will offer API manufacturing for oligonucleotides, peptides & conjugates at any scale.

Phase I of this development includes a large-scale manufacturing plant for oligonucleotides, peptides, and related synthetic conjugates. Operations are expected to commence in 2027.

Site Virtual Tour

How can we help?

Our TIDES Drug Experts Stand Ready.

Small Molecule Projects?

Scroll to Top
Please enable JavaScript in your browser to complete this form.
Checkboxes